SCHEMBL5380353

SCHEMBL5380353

Cc1cc(OCc2ccc(C(F)(F)F)cc2)ccc1NS(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.50
POLB P06746 3/20 0.49
KDM1A O60341 2/20 0.49
ADAMTS4 O75173 1/20 0.48
MMP13 P45452 1/20 0.48
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
PKM P14618 1/20 0.46
ACLY P53396 1/20 0.45
MCL1 Q07820 2/20 0.44
BCL2L1 Q07817 1/20 0.44
PPARA Q07869 2/20 0.43
PPARD Q03181 1/20 0.43
MAOB P27338 2/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
BLM P54132 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376847 0.89 AR (0.66) ARPOLBADAMTS4MMP13MEN1
SCHEMBL4905297 0.83 ADAMTS4 (0.50) ARPOLBADAMTS4MMP13MEN1
SCHEMBL5369951 0.81 POLB (0.52) ARPOLBMEN1KMT2APKM
SCHEMBL5372119 0.79 POLB (0.62) ARPOLBMEN1KMT2APKM
SCHEMBL5930857 0.79 ADAMTS4 (0.49) ARADAMTS4MMP13MCL1BCL2L1
SCHEMBL5380358 0.78 SERPINE1 (0.48) ARADAMTS4MMP13MEN1KMT2A
SCHEMBL5369923 0.77 AR (0.66) ARPOLBADAMTS4MMP13MEN1
SCHEMBL4905308 0.77 MMP2 (0.49) ADAMTS4MMP13KMT2AMCL1BCL2L1
SCHEMBL5368419 0.76 POLB (0.66) POLBKDM1AMEN1KMT2AACLY
SCHEMBL5380382 0.76 MEN1 (0.77) ARPOLBMEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD AR 885/4885POLB 1807/4885KDM1A 4634/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD AR 639/4885POLB 2006/4885KDM1A 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.